Cargando…
The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran
Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars prov...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300436/ https://www.ncbi.nlm.nih.gov/pubmed/30113147 http://dx.doi.org/10.4093/dmj.2018.0047 |
_version_ | 1783381679502524416 |
---|---|
author | Ghaem, Haleh Daneshi, Nima Riahi, Shirin Dianatinasab, Mostafa |
author_facet | Ghaem, Haleh Daneshi, Nima Riahi, Shirin Dianatinasab, Mostafa |
author_sort | Ghaem, Haleh |
collection | PubMed |
description | Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean±standard deviation age of the participants was 56.64±12.45 years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran. |
format | Online Article Text |
id | pubmed-6300436 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Korean Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-63004362018-12-24 The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran Ghaem, Haleh Daneshi, Nima Riahi, Shirin Dianatinasab, Mostafa Diabetes Metab J Short Communication Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean±standard deviation age of the participants was 56.64±12.45 years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran. Korean Diabetes Association 2018-12 2018-08-09 /pmc/articles/PMC6300436/ /pubmed/30113147 http://dx.doi.org/10.4093/dmj.2018.0047 Text en Copyright © 2018 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Short Communication Ghaem, Haleh Daneshi, Nima Riahi, Shirin Dianatinasab, Mostafa The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title_full | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title_fullStr | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title_full_unstemmed | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title_short | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
title_sort | prevalence and risk factors for diabetic retinopathy in shiraz, southern iran |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300436/ https://www.ncbi.nlm.nih.gov/pubmed/30113147 http://dx.doi.org/10.4093/dmj.2018.0047 |
work_keys_str_mv | AT ghaemhaleh theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT daneshinima theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT riahishirin theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT dianatinasabmostafa theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT ghaemhaleh prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT daneshinima prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT riahishirin prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT dianatinasabmostafa prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran |